tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

ADMA Biologics Inc

ADMA
Add to Watchlist
8.460USD
-0.210-2.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.96BMarket Cap
12.16P/E TTM

ADMA Biologics Inc

8.460
-0.210-2.42%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ADMA Financials

See ADMA Biologics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ADMA Biologics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/0.17
Revenue / Forecast
--/131.66M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
510.17M
19.63%
EPS(YoY)
0.62
-27.30%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
69.70%0.19
-56.15%0.21
-0.27%0.15
2.72%0.14
45.44%0.11
706.07%0.47
1243.99%0.15
582.17%0.14
354.33%0.08
-29.51%-0.08
--0.01
---0.03
---0.03
---0.06
---0.27
----
----
----
----
----
Revenue
-0.27%114.49M
18.39%139.16M
12.00%134.22M
13.80%121.98M
40.22%114.80M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
47.86%73.90M
63.72%67.27M
77.33%60.12M
95.56%56.91M
89.45%49.98M
98.69%41.09M
90.15%33.91M
81.34%29.10M
89.04%26.38M
101.24%20.68M
128.96%17.83M
Net Profit
68.48%45.33M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.90M
734.17%111.90M
1299.93%35.91M
603.27%32.06M
362.28%17.81M
-44.25%-17.64M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
26.53%-12.23M
15.88%-14.90M
27.19%-13.76M
-36.06%-25.01M
14.21%-16.65M
-4.70%-17.71M
6.31%-18.91M
Net Margin
68.94%39.59%
-62.72%35.48%
-9.43%27.14%
-6.22%28.05%
7.76%23.44%
498.70%95.19%
685.89%29.96%
382.28%29.91%
282.32%21.75%
2.44%-23.88%
--3.81%
---10.60%
---11.93%
---24.47%
---51.56%
----
----
----
----
----
Gross Margin
32.49%70.48%
18.43%63.78%
13.17%56.31%
3.03%55.09%
11.92%53.20%
28.81%53.86%
36.78%49.76%
72.72%53.47%
65.61%47.53%
49.28%41.81%
--36.38%
--30.96%
--28.70%
--28.01%
--19.74%
----
----
----
----
----
Debt to assets ratio
108.34%29.60%
-21.93%11.56%
-50.90%12.74%
-62.25%13.14%
-61.91%14.21%
-62.69%14.80%
-36.26%25.94%
-14.87%34.82%
-11.93%37.29%
-3.21%39.67%
--40.70%
--40.90%
--42.34%
--40.99%
--47.03%
----
----
----
----
----
Income Statement
Revenue
-0.27%114.49M
18.39%139.16M
12.00%134.22M
13.80%121.98M
40.22%114.80M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
47.86%73.90M
63.72%67.27M
77.33%60.12M
95.56%56.91M
89.45%49.98M
98.69%41.09M
90.15%33.91M
81.34%29.10M
89.04%26.38M
101.24%20.68M
128.96%17.83M
Operating profit
44.19%50.29M
63.74%62.75M
28.69%51.01M
9.18%42.80M
59.85%34.88M
169.25%38.32M
356.39%39.64M
1606.70%39.20M
2782.96%21.82M
334.93%14.23M
193.22%8.69M
125.03%2.30M
94.51%-813.32K
54.07%-6.06M
35.47%-9.32M
41.12%-9.17M
2.30%-14.82M
23.40%-13.19M
-4.61%-14.44M
9.01%-15.58M
Net Profit
68.48%45.33M
-55.87%49.38M
1.45%36.43M
6.73%34.22M
51.10%26.90M
734.17%111.90M
1299.93%35.91M
603.27%32.06M
362.28%17.81M
-44.25%-17.64M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
26.53%-12.23M
15.88%-14.90M
27.19%-13.76M
-36.06%-25.01M
14.21%-16.65M
-4.70%-17.71M
6.31%-18.91M
Balance Sheet
Current assets
45.30%511.17M
40.77%466.51M
26.54%402.65M
31.57%399.56M
27.28%351.81M
28.95%331.41M
16.26%318.19M
14.07%303.69M
4.67%276.42M
-4.95%257.01M
22.14%273.70M
19.51%266.24M
10.13%264.09M
29.55%270.40M
28.21%224.09M
30.01%222.77M
35.27%239.80M
35.77%208.73M
25.25%174.79M
19.84%171.36M
Total current liabilities
37.46%73.54M
25.20%69.54M
25.84%56.49M
69.64%74.94M
0.77%53.50M
11.52%55.54M
7.29%44.89M
5.30%44.18M
44.54%53.09M
26.84%49.81M
-5.85%41.84M
49.45%41.95M
16.35%36.73M
29.26%39.27M
37.43%44.44M
54.36%28.07M
48.86%31.57M
52.29%30.38M
96.30%32.34M
41.20%18.19M
Total assets
30.28%665.18M
27.74%624.24M
45.59%568.69M
48.35%558.38M
45.51%510.57M
48.45%488.68M
11.93%390.62M
9.73%376.40M
2.96%350.88M
-5.53%329.18M
16.12%349.00M
15.52%343.03M
10.63%340.79M
26.14%348.46M
25.95%300.56M
27.54%296.93M
30.71%308.03M
33.02%276.25M
25.62%238.64M
21.55%232.81M
Total liabilities
100.41%274.86M
5.20%146.92M
-13.37%137.50M
-14.92%160.06M
-30.44%137.15M
-28.00%139.66M
-19.66%158.73M
-4.14%188.13M
1.04%197.17M
-1.28%193.98M
-1.31%197.56M
7.52%196.26M
7.75%195.13M
45.46%196.49M
47.34%200.17M
50.58%182.53M
47.04%181.10M
13.11%135.08M
14.55%135.86M
5.72%121.22M
Total equity
4.53%390.32M
36.76%477.32M
85.94%431.19M
111.57%398.32M
142.94%373.42M
158.14%349.02M
53.13%231.89M
28.28%188.27M
5.53%153.71M
-11.03%135.21M
50.86%151.44M
28.29%146.76M
14.75%145.65M
7.65%151.97M
-2.33%100.38M
2.52%114.40M
12.83%126.93M
59.97%141.17M
44.00%102.78M
45.15%111.59M
Cash Flow Statement
Net operating income
396.06%58.25M
-29.03%35.64M
-46.89%13.29M
-53.69%21.14M
-787.06%-19.68M
185.38%50.22M
108.83%25.03M
853.39%45.65M
84.93%-2.22M
338.45%17.60M
190.22%11.99M
52.78%-6.06M
43.41%-14.72M
77.95%-7.38M
0.95%-13.28M
60.23%-12.83M
21.72%-26.01M
-3.87%-33.47M
43.77%-13.41M
-51.58%-32.26M
Net investment
150.93%2.40M
53.60%-1.28M
-1208.56%-14.37M
-6.85%-2.53M
-99.83%-4.72M
-95.42%-2.75M
-45.13%-1.10M
-171.02%-2.37M
-21.46%-2.36M
62.46%-1.41M
77.62%-756.56K
77.85%-872.63K
31.58%-1.94M
-1.98%-3.75M
-21.22%-3.38M
11.96%-3.94M
-10.54%-2.84M
-2.15%-3.68M
3.34%-2.79M
-7.37%-4.48M
Net financing
-42.14%-10.13M
70.61%-9.12M
-9.26%-27.82M
113.26%48.00K
-392.54%-7.13M
20.43%-31.03M
-6231.38%-25.47M
-250.76%-362.00K
-122.44%-1.45M
-162.15%-38.99M
149.22%415.36K
175.26%240.12K
-101.38%-650.51K
16.58%62.74M
-110.29%-843.79K
-101.86%-319.04K
12.97%47.27M
67.85%53.82M
-22.84%8.20M
1014330.22%17.18M

FAQs

What is the total revenue of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its total revenue reached 510.17M, with a year-on-year change of 426.45M.

What are the current assets of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its current assets were 466.51M, with a year-on-year change of 40.77.

What are the total assets of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its total assets of ADMA Biologics Inc were 624.24M, with a year-on-year change of 27.74.

What are the total liabilities of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its total liabilities of ADMA Biologics Inc were 146.92M, with a year-on-year change of 5.20.

What is the total equity of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its total equity of ADMA Biologics Inc was 477.32M, with a year-on-year change of 36.76.

What is the net operating income of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its net operating income of ADMA Biologics Inc was 191.44M, with a year-on-year change of 37.75.

What is the net investment of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its net investment of ADMA Biologics Inc was -22.89M, with a year-on-year change of -166.95.

What is the net financing of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its net financing of ADMA Biologics Inc was -44.02M, with a year-on-year change of 24.49.

What is the Earnings Per Share (EPS) of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.62, with a year-on-year change of -27.30.

What is the net income of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its net income was 146.93M, with a year-on-year change of -25.67.

What is the net margin of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its net profit margin was 28.80, with a year-on-year change of -37.87.

What is the gross margin of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its gross margin was 57.36, with a year-on-year change of 11.61.

What is the debt-to-asset ratio of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its debt-to-asset ratio was 11.56, with a year-on-year change of -21.93.

What is the Return on Equity (ROE) of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its Return on Equity (ROE) was 35.56, with a year-on-year change of -56.44.

What is the Return on Assets (ROA) of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its Return on Assets (ROA) was 26.40, with a year-on-year change of -45.38.

What is the operating profit of ADMA Biologics Inc?

According to ADMA Biologics Inc's FY2025 earnings report, its operating profit was 191.44M, with a year-on-year change of 37.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy